-
Loading metrics
A drug repurposing screen reveals dopamine signaling as a critical pathway underlying potential therapeutics for the rare disease DPAGT1-CDG
-
Hans M. Dalton,
Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing
Current address: Department of Molecular Biosciences, University of Kansas, Lawrence, Kansas, United States of America
Affiliation Department of Human Genetics, University of Utah School of Medicine, Salt Lake City, Utah, United States of America
⨯ - Naomi J. Young,
- Alexys R. Berman,
- Heather D. Evans,
-
Sydney J. Peterson,
Roles Investigation
Affiliation Department of Human Genetics, University of Utah School of Medicine, Salt Lake City, Utah, United States of America
⨯ - Kaylee A. Patterson,
-
Clement Y. Chow
Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Supervision, Validation, Visualization, Writing – review & editing
* E-mail: cchow@genetics.utah.edu
Affiliation Department of Human Genetics, University of Utah School of Medicine, Salt Lake City, Utah, United States of America
⨯
https://orcid.org/0000-0001-7916-1015
A drug repurposing screen reveals dopamine signaling as a critical pathway underlying potential therapeutics for the rare disease DPAGT1-CDG
- Hans M. Dalton,
- Naomi J. Young,
- Alexys R. Berman,
- Heather D. Evans,
- Sydney J. Peterson,
- Kaylee A. Patterson,
- Clement Y. Chow
-
- Published: October 28, 2024
- https://doi.org/10.1371/journal.pgen.1011458